Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Korro Bio (KRRO)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 33,650,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Frequency Therapeutics is a clinical-stage biotechnology company focused on developing therapeutics to activate a person's innate regenerative potential to restore function. Co. develops FX-322 to treat an underlying cause of sensorineural hearing loss, which is the loss of hair cells. Co.'s proprietary approach, Progenitor Cell Activation, uses small molecules to activate progenitor cells within the body to create functional tissue. These progenitor cells, which are closely related to stem cells, are already resident in the targeted location in the body and programmed to develop and differentiate into specific cell types within an organ.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 178,570 178,570 178,570 178,570
Total Buy Value $9,999,920 $9,999,920 $9,999,920 $9,999,920
Total People Bought 10 10 10 10
Total Buy Transactions 10 10 10 10
Total Shares Sold 0 1,156 134,724 157,951
Total Sell Value $0 $43,573 $154,141 $189,534
Total People Sold 0 1 3 6
Total Sell Transactions 0 1 94 99
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 299
  Page 9 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lucchino David L. President and CEO   •       •      –    2021-02-01 4 AS $41.29 $1,426,370 D/D (33,102) 308,086     -
   Lucchino David L. President and CEO   •       •      –    2021-02-01 4 OE $0.61 $20,192 D/D 33,102 341,188     -
   Lucchino David L. President and CEO   •       •      –    2021-01-27 4 AS $42.50 $390,830 D/D (9,196) 308,086     -
   Lucchino David L. President and CEO   •       •      –    2021-01-27 4 OE $0.61 $5,610 D/D 9,196 317,282     -
   Loose Christopher R. Chief Scientific Officer   •       •      –    2021-01-27 4 AS $42.50 $340,000 D/D (8,000) 31,782     -
   Bookman Michael General Counsel and SecretaryO   •       –      –    2021-01-19 3 IO $0.00 $0 D/D 0 9,236     -
   Lucchino David L. President and CEO   •       •      –    2021-01-06 4 AS $36.13 $1,063,917 D/D (27,586) 308,086     -
   Lucchino David L. President and CEO   •       •      –    2021-01-06 4 OE $0.61 $16,827 D/D 27,586 335,672     -
   Lucchino David L. President and CEO   •       •      –    2021-01-04 4 AS $32.89 $1,132,740 D/D (34,104) 308,086     -
   Lucchino David L. President and CEO   •       •      –    2021-01-04 4 OE $0.61 $11,218 D/D 18,390 342,190     -
   Marcus Joel S Director   •       •      –    2020-12-22 4 S $32.09 $672,134 D/D (20,000) 270,000     -
   Marcus Joel S Director   •       •      –    2020-12-21 4 S $30.35 $303,521 D/D (10,000) 290,000     -
   Marcus Joel S Director   •       •      –    2020-12-18 4 S $33.92 $726,757 D/D (19,700) 300,000     -
   Lucchino David L. President and CEO   •       •      –    2020-12-17 4 AS $42.64 $47,755 D/D (1,120) 323,800     -
   Lucchino David L. President and CEO   •       •      –    2020-12-17 4 OE $0.61 $683 D/D 1,120 324,920     -
   Loose Christopher R. Chief Scientific Officer   •       •      –    2020-12-17 4 AS $40.00 $325,001 D/D (8,000) 39,782     -
   Loose Christopher R. Chief Scientific Officer   •       •      –    2020-12-16 4 AS $37.87 $311,480 D/D (8,000) 47,782     -
   Lucchino David L. President and CEO   •       •      –    2020-12-16 4 AS $40.00 $540,560 D/D (13,514) 323,800     -
   Lucchino David L. President and CEO   •       •      –    2020-12-16 4 OE $0.61 $8,244 D/D 13,514 337,314     -
   Loose Christopher R. Chief Scientific Officer   •       •      –    2020-12-15 4 AS $37.28 $298,240 D/D (8,000) 55,782     -
   Lucchino David L. President and CEO   •       •      –    2020-12-15 4 AS $38.18 $518,890 D/D (13,514) 323,800     -
   Lucchino David L. President and CEO   •       •      –    2020-12-15 4 OE $0.61 $8,244 D/D 13,514 337,314     -
   Loose Christopher R. Chief Scientific Officer   •       •      –    2020-12-14 4 AS $35.00 $280,000 D/D (8,000) 63,782     -
   Lucchino David L. President and CEO   •       •      –    2020-12-14 4 AS $35.12 $474,612 D/D (13,514) 323,800     -
   Lucchino David L. President and CEO   •       •      –    2020-12-14 4 OE $0.61 $8,244 D/D 13,514 337,314     -
  299 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us